Virtual Practice
Recommend

Dr. Carlos Encarnacion

Internal Medicine - Oncology
Waco, TX
About
Insights
Network
Welcome!
About me
I specialize in
Internal Medicine - Oncology
Clinical Genetics
Internal Medicine
I have been in practice
33 years
I speak
English
Español
I'm known for
Doctor
Votes
Member
Votes
Cancer
18th
Nationally
279
Female Health
--
Locally
35
Breast cancer
16th
Nationally
81
Recommend me
My answers and insights have
Saved 3 lives
Helped 2,741,805 people
Received 3,017 doctor agrees
Received 818 thanks
Here are kind words from others
I learn a great deal from the information that Dr. Encarnacion provides. He is clearly very knowledgeable about oncology and medicine in general. I endorse Dr. Encarnacion.
I highly recommend Dr. Carlos Encarnacion. He is highly knowledgeable and caring.
Very accurate and timely responses.
Excellent physician!
excellent physician
Recommend me
I am located at
Texas Oncology Horizon Circle
6520 Horizon Circle
Waco , TX 76712
Office hours
Mon 9:00am - 5:00pm
Tue 9:00am - 5:00pm
Wed 9:00AM - 5:00PM
Thu 9:00AM - 12:00PM
Fri 9:00am - 5:00am
Accepted Insurance Plans
I was educated and trained at
Medical / Graduate School
University of Puerto Rico School of Medicine, PR
1986
Academic Appointments
Assistant Professor of Medicine, University of Puerto Rico 1989-1990
Chief Resident, San Juan VA Hospital 1989-1990
I'm affiliated with
Hospitals
HILLCREST BAPTIST MEDICAL CENTER
PROVIDENCE HEALTH CENTER
GOODALL WITCHER HOSPITAL
I've won the following awards
Top Oncologist , Texas
Winter 2013
Thought Leader, Waco, TX
Winter 2013
Most Influential, Waco, TX
Winter 2013
I've published
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
Breast cancer research and treatment, 118, 361-7 (2009)
J W Smith, K J McIntyre, P V Acevedo, C A Encarnacion, K L Tedesco, Y Wang, L Asmar, J A O'Shaughnessy
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, 1426-31 (2009)
M G Teneriello, P C Tseng, M Crozier, C Encarnacion, K Hancock, M J Messing, K A Boehm, A Williams, L Asmar
Results of a phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer.
Clinical colorectal cancer, 5, 50-6 (2005)
T Cartwright, T Lopez, S J Vukelja, C Encarnacion, K A Boehm, L Asmar
Here are some of my top insights